Sun Pharma Advanced Research Com Profit & Loss Annual

Trade
BSE: 532872 | NSE: SPARC | ISIN: INE232I01014 | Sector: Business Services
370.35 +1.55 (0.42%)Updated : 28 Mar 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 238.78137.25252.9676.81
Total Revenue 238.78137.25252.9676.81
Costof Revenue Total 34.3230.7036.7057.02
Gross Profit 204.46106.55216.2619.80
Selling/ General/ Admin Expenses Total 412.84290.89347.56323.00
Depreciation/ Amortization 11.7710.1610.929.48
Other Operating Expenses Total 3.501.573.482.27
Total Operating Expense 462.42333.32398.66391.77
Operating Income -223.64-196.07-145.70-314.95
Interest Inc( Exp) Net- Non- Op Total 11.57-124.81-61.7218.60
Gain( Loss)on Saleof Assets -0.9648.932.640.00
Net Income Before Taxes -222.58-203.40-151.14-312.40
Provisionfor Income Taxes 0.000.000.000.00
Net Income After Taxes -222.58-203.40-151.14-312.40
Net Income Before Extra Items -222.58-203.40-151.14-312.40
Net Income -222.58-203.40-151.14-312.40
Income Availableto Com Excl Extra Ord -222.58-203.40-151.14-312.40
Income Availableto Com Incl Extra Ord -222.58-203.40-151.14-312.40
Diluted Net Income -222.58-203.40-151.14-312.40
Diluted Weighted Average Shares 28.4726.3126.2026.20
Diluted EPS Excluding Extra Ord Items -7.82-7.73-5.77-11.92
Diluted Normalized EPS -7.81-7.92-5.78-11.92
Other Net -0.270.470.69
*All figures in crores except per share values
Recommended For You
Images
Trending Stocks
1,643.05+61.85(3.91%)
7,240.35+217.15(3.09%)
1,048.30-5.30 (-0.50%)
2,976.80-11.05 (-0.37%)